Home › Funds › ASHFORD CAPITAL MANAGEMENT INC › LGND
ASHFORD CAPITAL MANAGEMENT INC position in LGND
LIGAND PHARMACEUTICALS INC · Health Care
ASHFORD CAPITAL MANAGEMENT INC reported holding 166,336 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$52.0M, representing 5.62% of its reported portfolio and ranking #1 among its reported holdings. ASHFORD CAPITAL MANAGEMENT INC has disclosed LGND holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ASHFORD CAPITAL MANAGEMENT INC's LGND position evolved
ASHFORD CAPITAL MANAGEMENT INC first disclosed a stake in LGND in Q1 2024 at 196,535 shares (US$14.4M). The position peaked in Q2 2026 at 170,236 shares, worth US$53.8M. Across 11 filings, ASHFORD CAPITAL MANAGEMENT INC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 166,336 shares valued at US$52.0M — a reduction of -3,900 shares quarter over quarter.. Notable position changes include a 64% increase in Q2 2024 (shares rose 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 196.53K | $14.37M | New |
| Q2 2024 | 322.21K | $27.15M | Add |
| Q3 2024 | 310.41K | $31.07M | Reduce |
| Q4 2024 | 310.66K | $33.29M | Hold |
| Q1 2025 | 298.04K | $31.34M | Reduce |
| Q2 2025 | 302.53K | $34.39M | Add |
| Q3 2025 | 244.43K | $43.30M | Reduce |
| Q4 2025 | 213.78K | $40.42M | Reduce |
| Q1 2026 | 207.56K | $41.44M | Reduce |
| Q2 2026 | 170.24K | $53.81M | Reduce |
| Q3 2026 | 166.34K | $51.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- CONGRESS ASSET MANAGEMENT CO 658.56K sh · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 446.14K sh · $139.36M · Q3 2026
- WOLVERINE ASSET MANAGEMENT LLC 50.37M sh · $84.80M · Q3 2026
- GW&K Investment Management, LLC 241.76K sh · $75.52M · Q3 2026
- RICE HALL JAMES & ASSOCIATES, LLC 223.91K sh · $69.94M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 192.39K sh · $60.10M · Q3 2026
- Ranger Investment Management, L.P. 185.65K sh · $57.99M · Q3 2026
- Private Capital Management, LLC 166.02K sh · $52.48M · Q2 2026
- Granahan Investment Management, LLC 154.32K sh · $48.20M · Q3 2026
- SILVERBACK ASSET MANAGEMENT LLC 25.00M sh · $42.00M · Q3 2026
More on ASHFORD CAPITAL MANAGEMENT INC
FAQ
How long has ASHFORD CAPITAL MANAGEMENT INC held LGND?
ASHFORD CAPITAL MANAGEMENT INC has disclosed LGND holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is ASHFORD CAPITAL MANAGEMENT INC's current position in LGND?
As of Q3 2026, ASHFORD CAPITAL MANAGEMENT INC holds 166.34K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $51.96M, representing 5.62% of its reported portfolio and ranking #1.
Has ASHFORD CAPITAL MANAGEMENT INC been buying or selling LGND?
In the latest 13F filing (Q3 2026), ASHFORD CAPITAL MANAGEMENT INC reduced its position in LGND. The position peaked in Q2 2026 at 170.24K shares.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.